|Bid||1.22 x 1000|
|Ask||1.62 x 800|
|Day's Range||1.4600 - 1.4950|
|52 Week Range||1.1000 - 15.9000|
|Beta (3Y Monthly)||1.31|
|PE Ratio (TTM)||1.21|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Sarepta (SRPT) inks long-term strategic deal with Aldevron for the supply of plasmid DNA to fulfill the former's needs for its gene-therapy clinical trials and commercial supply.
This article is intended for those of you who are at the beginning of your investing journey and want to learn about Return on Equity using a real-life example. SummitRead More...